- 4-Week # shares sold: 7,500
- 12-Week # shares sold: 7,500
- 24-Week # shares sold: 7,500
Are the Baker Brothers selling Seattle Genetics? Biomarin CEO throws shade on Sarepta. TG Therapeutics management adds to its credibility problem.
Here are Thursday's top research calls, including upgrades for Dick's Sporting Goods and Seattle Genetics, and downgrades for Cognizant and VF Corp.